about
Antagonist HIV-1 Gag peptides induce structural changes in HLA B8The Role of Alternative Splicing in the Control of Immune Homeostasis and Cellular DifferentiationThe tyrosine phosphatase PTP1C associates with Vav, Grb2, and mSos1 in hematopoietic cellsClonal anergy induced in a CD8+ hapten-specific cytotoxic T-cell clone by an altered hapten-peptide ligandRegulation of colony-stimulating factor 1 receptor signaling by the SH2 domain-containing tyrosine phosphatase SHPTP1Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapyEvolutionary dynamics of HIV-induced subversion of the immune response.Natural epitope variants of the hepatitis C virus impair cytotoxic T lymphocyte activityManipulating antigenic ligand strength to selectively target myelin-reactive CD4+ T cells in EAE.Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand.Use of altered peptide ligands to modulate immune responses as a possible immunotherapy for allergies.Dissociation of peripheral T cell responses from thymocyte negative selection by weak agonists supports a spare receptor model of T cell activation.Analysis of competition binding between soluble and membrane-bound ligands for cell surface receptors.Studies of human antiviral CD8+ lymphocytes using class I peptide tetramers.Low 2-dimensional CD4 T cell receptor affinity for myelin sets in motion delayed response kinetics.The T cell receptor for antigen: signaling and ligand discrimination.The physiological role of regulatory T cells in the prevention of autoimmunity: the function of the thymus in the generation of the regulatory T cell subset.Multi-modal antigen specific therapy for autoimmunity.CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics.Epitope-specific CD8+ T lymphocytes cross-recognize mutant simian immunodeficiency virus (SIV) sequences but fail to contain very early evolution and eventual fixation of epitope escape mutations during SIV infection.The formation and functions of the 21- and 23-kDa tyrosine-phosphorylated TCR zeta subunits.Kinetic perspectives of T cell antigen receptor signaling. A two-tier model for T cell full activation.A primer on cytokines: sources, receptors, effects, and inducersPreferential usage of the T-cell receptor by influenza virus hemagglutinin-specific human CD4+ T lymphocytes: in vitro life span of clonotypic T cells.Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection.Cooperative enhancement of specificity in a lattice of T cell receptors.Antibody-mediated targeting of CD45 isoforms: a novel immunotherapeutic strategy.Antigen-specific inhibition of CD4(+) T-cell responses to β-lactoglobulin by its single amino acid-substituted mutant form through T-cell receptor antagonism.Involvement of both major histocompatibility complex class II alpha and beta chains in CD4 function indicates a role for ordered oligomerization in T cell activationPartial signaling by CD8+ T cells in response to antagonist ligands.Selective activation of the calcium signaling pathway by altered peptide ligandsGlucocorticoids attenuate T cell receptor signaling.Partially phosphorylated T cell receptor zeta molecules can inhibit T cell activation.Functional inactivation in the whole population of human V gamma 9/V delta 2 T lymphocytes induced by a nonpeptidic antagonistThe efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide-MHC molecule ligands.Kinetics and extent of T cell activation as measured with the calcium signalPersistence of peptide-induced CD4+ T cell anergy in vitroInhibition of immune responses by ITAM-bearing receptors.Selective induction of apoptosis in mature T lymphocytes by variant T cell receptor ligands.CD3 ligation on immature thymocytes generates antagonist-like signals appropriate for CD8 lineage commitment, independently of T cell receptor specificity.
P2860
Q24309337-ECE3693D-D909-454E-B46C-D14AC90FE313Q26772026-869418B1-3DE3-4DC4-B4C2-78DAE3071BE1Q28279049-09511F16-E5EA-4690-AB65-9A45996F2D6BQ28347348-994696E5-6FF6-44F6-B78F-97B5653D3CA3Q30176913-F6CD7FF3-A10F-449F-AD1A-45E6A7C536F3Q30305530-078D8128-2604-4E70-9365-3E2D4670E604Q33683341-1117E28B-DEE6-4753-B5AD-79C9AA75AA32Q33812154-22571509-668F-407A-93FE-A24E33075D6CQ33838467-65D8BDB9-1E1C-4455-8881-E04448DD62B8Q33853487-A4D7D181-DA49-4400-AA66-C8CC13C5D93AQ33987217-8D07A94C-1E95-4F89-B861-7FBD0805F012Q34048781-0FC28E05-D0C4-4E19-B7AE-2172D4143E64Q34172091-2ED34DC5-2C55-47B0-A631-20B168F7F5E9Q34176576-4E1037C1-5411-4269-A7E1-FE1DE3E4F1DDQ34193211-A432FF14-068A-485A-B418-5479F46DAF14Q34297955-7808B273-1CBF-412D-955D-9C895CE58239Q34414103-3A3072D7-80CF-4779-B345-727586AD362BQ34560522-779C2A81-2A0C-455D-951B-8BB9B6C263E6Q34738334-1A556E1E-A269-4394-884E-878CB12DBD05Q35076549-3583B6A8-24F7-493D-82D0-AE3F4C4CD614Q35076675-D0CF581A-C047-4B8A-A575-8EB8D87A59D9Q35076704-AE007C85-E316-43C9-8C7F-07B253AE0C98Q35376246-4D9B696A-DC11-461D-B53C-962829431A04Q35852655-B42D7399-D15C-47E8-94E7-6A4A62C9BE25Q35884259-ABBBD067-5A21-4410-B54C-8DE0FC254895Q35894714-CBEF5D6F-595C-40FF-BC12-F18E51AA3547Q36010833-3A7CCF1A-1658-471B-B00E-EBB2EE4CA450Q36304701-B09E4FE1-99F5-4EBB-BD16-9D57946F3745Q36365326-805118BF-8B9E-474E-873E-90CCCD1B22EAQ36367003-5FABC5FE-BDF2-4E4C-8E0E-451234A3FAA5Q36367455-BF486C3C-E506-42FB-8C09-287808B77F97Q36369133-25DB21AB-A66F-4718-B1DB-23A72921E3C7Q36375671-B92C8BAE-5A9F-40A9-909F-3D669B8C6A4AQ36376704-7C4311A5-A5A6-46A7-ACAC-F0FBA7D6FACDQ36376752-33363C68-A05A-4318-8F4D-E3F7C5F042F4Q36377251-A3BE7130-FEC3-493A-B220-B70943778F98Q36381014-61339D2D-F731-41E2-8552-F79F86B5EBDBQ36383231-25EC0650-3044-4658-9870-D7D803D60ED8Q36400233-78B8BC63-9E37-48B6-B272-6D75B0F90697Q36400625-2E90B297-C429-4231-8995-C66132747C0F
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
T cell receptor antagonists and partial agonists.
@en
type
label
T cell receptor antagonists and partial agonists.
@en
prefLabel
T cell receptor antagonists and partial agonists.
@en
P1433
P1476
T cell receptor antagonists and partial agonists.
@en
P2093
S C Jameson
P356
10.1016/1074-7613(95)90074-8
P407
P577
1995-01-01T00:00:00Z